QuidelOrtho Corporation (NASDAQ: QDEL) Stock Competitors & Peer Comparison
See QDEL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for QDEL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QDEL | $10.49 | -3.13% | 722.5M | 7.91 | $1.34 | N/A |
| ALC | $64.71 | -0.85% | 31.9B | 20.58 | $3.18 | +0.55% |
| STE | $210.45 | -0.26% | 20.5B | 20.21 | $10.42 | +1.23% |
| MLAB | $131.86 | -0.85% | 732.9M | 13.22 | $9.91 | +0.49% |
| BWAY | $13.34 | +0.69% | 528.7M | 34.24 | $0.39 | N/A |
| MASS | $12.22 | +4.82% | 486.2M | -19.75 | -$0.60 | N/A |
| SI | $19.19 | +6.91% | 391.3M | -10.91 | -$1.73 | N/A |
| MOBI | $9.31 | +5.48% | 299.9M | -4.67 | -$1.93 | N/A |
| LAB | $0.74 | +1.88% | 279.2M | -10.19 | -$0.07 | N/A |
| ANIK | $19.88 | -3.86% | 266.9M | 40.70 | $0.49 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
QDEL vs ALC Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, ALC has a market cap of 31.9B. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while ALC trades at $64.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas ALC's P/E ratio is 20.58. In terms of profitability, QDEL's ROE is -0.55%, compared to ALC's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check ALC's competition here
STERIS plc (NYSE: STE)
QDEL vs STE Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, STE has a market cap of 20.5B. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while STE trades at $210.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas STE's P/E ratio is 20.21. In terms of profitability, QDEL's ROE is -0.55%, compared to STE's ROE of +0.11%. Regarding short-term risk, QDEL is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
QDEL vs MLAB Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, MLAB has a market cap of 732.9M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while MLAB trades at $131.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas MLAB's P/E ratio is 13.22. In terms of profitability, QDEL's ROE is -0.55%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
QDEL vs BWAY Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, BWAY has a market cap of 528.7M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while BWAY trades at $13.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas BWAY's P/E ratio is 34.24. In terms of profitability, QDEL's ROE is -0.55%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, QDEL is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
QDEL vs MASS Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, MASS has a market cap of 486.2M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while MASS trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas MASS's P/E ratio is -19.75. In terms of profitability, QDEL's ROE is -0.55%, compared to MASS's ROE of -0.25%. Regarding short-term risk, QDEL is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
QDEL vs SI Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, SI has a market cap of 391.3M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while SI trades at $19.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas SI's P/E ratio is -10.91. In terms of profitability, QDEL's ROE is -0.55%, compared to SI's ROE of -0.26%. Regarding short-term risk, QDEL is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
QDEL vs MOBI Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, MOBI has a market cap of 299.9M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while MOBI trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas MOBI's P/E ratio is -4.67. In terms of profitability, QDEL's ROE is -0.55%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, QDEL is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
QDEL vs LAB Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, LAB has a market cap of 279.2M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while LAB trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas LAB's P/E ratio is -10.19. In terms of profitability, QDEL's ROE is -0.55%, compared to LAB's ROE of -0.18%. Regarding short-term risk, QDEL is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check LAB's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
QDEL vs ANIK Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, ANIK has a market cap of 266.9M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while ANIK trades at $19.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas ANIK's P/E ratio is 40.70. In terms of profitability, QDEL's ROE is -0.55%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, QDEL is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check ANIK's competition here
Edap Tms S.a. (NASDAQ: EDAP)
QDEL vs EDAP Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas EDAP's P/E ratio is -5.80. In terms of profitability, QDEL's ROE is -0.55%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, QDEL is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
QDEL vs NYXH Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, NYXH has a market cap of 137.1M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while NYXH trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas NYXH's P/E ratio is -0.54. In terms of profitability, QDEL's ROE is -0.55%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, QDEL is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
QDEL vs TRIB Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, TRIB has a market cap of 135.7M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while TRIB trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas TRIB's P/E ratio is -0.11. In terms of profitability, QDEL's ROE is -0.55%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, QDEL is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
QDEL vs APYX Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, APYX has a market cap of 109.5M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while APYX trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas APYX's P/E ratio is -13.00. In terms of profitability, QDEL's ROE is -0.55%, compared to APYX's ROE of -0.79%. Regarding short-term risk, QDEL is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
QDEL vs SKIN Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, SKIN has a market cap of 80.5M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while SKIN trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas SKIN's P/E ratio is -2.82. In terms of profitability, QDEL's ROE is -0.55%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, QDEL is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
QDEL vs MDAI Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, MDAI has a market cap of 50.3M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while MDAI trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas MDAI's P/E ratio is -3.51. In terms of profitability, QDEL's ROE is -0.55%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, QDEL is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
QDEL vs DRIO Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, DRIO has a market cap of 48.4M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while DRIO trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas DRIO's P/E ratio is -1.13. In terms of profitability, QDEL's ROE is -0.55%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, QDEL is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
QDEL vs BEAT Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, BEAT has a market cap of 20.4M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while BEAT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas BEAT's P/E ratio is -0.72. In terms of profitability, QDEL's ROE is -0.55%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, QDEL is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check BEAT's competition here
Spectral AI, Inc. (NASDAQ: MDAIW)
QDEL vs MDAIW Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, MDAIW has a market cap of 14.8M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while MDAIW trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas MDAIW's P/E ratio is -1.31. In terms of profitability, QDEL's ROE is -0.55%, compared to MDAIW's ROE of N/A. Regarding short-term risk, QDEL is more volatile compared to MDAIW. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MDAIW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
QDEL vs BEATW Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, BEATW has a market cap of 6.3M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas BEATW's P/E ratio is -0.02. In terms of profitability, QDEL's ROE is -0.55%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, QDEL is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
QDEL vs WOK Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, WOK has a market cap of 4.5M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while WOK trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas WOK's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.55%, compared to WOK's ROE of -0.19%. Regarding short-term risk, QDEL is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
QDEL vs QTEXW Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, QDEL's ROE is -0.55%, compared to QTEXW's ROE of N/A. Regarding short-term risk, QDEL is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
QDEL vs ITOC Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, ITOC has a market cap of 2.5M. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while ITOC trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas ITOC's P/E ratio is -0.86. In terms of profitability, QDEL's ROE is -0.55%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, QDEL is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
QDEL vs FEED Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas FEED's P/E ratio is -0.15. In terms of profitability, QDEL's ROE is -0.55%, compared to FEED's ROE of -0.60%. Regarding short-term risk, QDEL is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
QDEL vs TIVC Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 722.5M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, QDEL is priced at $10.49 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 7.91, whereas TIVC's P/E ratio is -0.04. In terms of profitability, QDEL's ROE is -0.55%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, QDEL is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check TIVC's competition here